30779332|t|Nasal delivery of Fasudil-modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis.
30779332|a|AIM: Multiple sclerosis (MS) is a relapsing-remitting inflammatory demyelinating disease that requires long-term treatment. Although Rho kinase inhibitor Fasudil shows good therapeutic effect in experimental autoimmune encephalomyelitis (EAE), an animal model of MS, certain side effects may limit its clinical use. This study aimed at observing the therapeutic potential of Fasudil-modified encephalitogenic mononuclear cells (MNCs) via nasal delivery in EAE and exploring possible mechanisms of action. METHODS: Experimental autoimmune encephalomyelitis was induced with myelin oligodendrocyte glycoprotein 35-55 in C57BL/6 mice, and encephalitogenic MNCs were treated with Fasudil in vitro. Mice received 3 x 106  cells/10 muL per nasal cavity on day 3 and 11 postimmunization, respectively. RESULTS: Fasudil-modified MNCs reduced clinical severity of EAE, improved demyelination, and decreased inflammatory cells in spinal cords. Immunohistochemical results indicated that CD4+ T cells and CD68+ macrophages were barely detected in Fasudil-MNCs group. Fasudil-modified MNCs decreased CD4+ IFN-gamma+ and CD4+ IL-17+ T cells, increased CD4+ IL-10+ T cells, restrained M1 markers CD16/32, CCR7, IL-12, CD8a, enhanced M2 markers CD206, CD200, CD14 in spleen. Fasudil-modified MNCs inhibited the activation of inflammatory signaling p-NF-kB/P38, accompanied by the decrease of COX-2 and the increase of Arg-1 in spinal cord, as well as the reduction of IL-17, TNF-alpha, IL-6 and the elevation of IL-10 in cultured supernatant of splenocytes. Fasudil-modified MNCs enhanced the levels of neurotrophic factors BDNF and NT-3 in spinal cord. CONCLUSION: Our results indicate that intranasal delivery of Fasudil-modified MNCs have therapeutic potential in EAE, providing a safe and effective cell therapeutic strategy to MS and/or other related disorders.
30779332	82	123	experimental autoimmune encephalomyelitis	Disease	MESH:D004681
30779332	130	148	Multiple sclerosis	Disease	MESH:D009103
30779332	150	152	MS	Disease	MESH:D009103
30779332	159	213	relapsing-remitting inflammatory demyelinating disease	Disease	MESH:D020529
30779332	258	268	Rho kinase	Gene	19878
30779332	279	286	Fasudil	Chemical	MESH:C049347
30779332	320	361	experimental autoimmune encephalomyelitis	Disease	MESH:D004681
30779332	363	366	EAE	Disease	MESH:D004681
30779332	388	390	MS	Disease	MESH:D009103
30779332	500	507	Fasudil	Chemical	MESH:C049347
30779332	581	584	EAE	Disease	MESH:D004681
30779332	639	680	Experimental autoimmune encephalomyelitis	Disease	MESH:D004681
30779332	743	750	C57BL/6	CellLine	CVCL:C0MU
30779332	751	755	mice	Species	10090
30779332	801	808	Fasudil	Chemical	MESH:C049347
30779332	819	823	Mice	Species	10090
30779332	929	936	Fasudil	Chemical	MESH:C049347
30779332	980	983	EAE	Disease	MESH:D004681
30779332	994	1007	demyelination	Disease	MESH:D003711
30779332	1023	1035	inflammatory	Disease	MESH:D007249
30779332	1102	1105	CD4	Gene	12504
30779332	1119	1123	CD68	Gene	12514
30779332	1161	1168	Fasudil	Chemical	MESH:C049347
30779332	1181	1188	Fasudil	Chemical	MESH:C049347
30779332	1213	1216	CD4	Gene	12504
30779332	1218	1227	IFN-gamma	Gene	15978
30779332	1233	1236	CD4	Gene	12504
30779332	1238	1243	IL-17	Gene	16171
30779332	1264	1267	CD4	Gene	12504
30779332	1269	1274	IL-10	Gene	16153
30779332	1307	1314	CD16/32	Gene	14131;14130
30779332	1316	1320	CCR7	Gene	12775
30779332	1329	1333	CD8a	Gene	12525
30779332	1355	1360	CD206	Gene	17533
30779332	1362	1367	CD200	Gene	17470
30779332	1369	1373	CD14	Gene	12475
30779332	1385	1392	Fasudil	Chemical	MESH:C049347
30779332	1435	1447	inflammatory	Disease	MESH:D007249
30779332	1466	1469	P38	Gene	26416
30779332	1502	1507	COX-2	Gene	17709
30779332	1528	1533	Arg-1	Gene	11846
30779332	1578	1583	IL-17	Gene	16171
30779332	1585	1594	TNF-alpha	Gene	21926
30779332	1596	1600	IL-6	Gene	16193
30779332	1622	1627	IL-10	Gene	16153
30779332	1668	1675	Fasudil	Chemical	MESH:C049347
30779332	1734	1738	BDNF	Gene	12064
30779332	1743	1747	NT-3	Gene	18205
30779332	1877	1880	EAE	Disease	MESH:D004681
30779332	1942	1944	MS	Disease	MESH:D009103
30779332	Positive_Correlation	MESH:C049347	18205
30779332	Negative_Correlation	MESH:C049347	26416
30779332	Positive_Correlation	MESH:C049347	MESH:D003711
30779332	Negative_Correlation	MESH:C049347	MESH:D004681
30779332	Association	MESH:D007249	26416
30779332	Positive_Correlation	MESH:C049347	12475
30779332	Positive_Correlation	MESH:C049347	11846
30779332	Association	MESH:C049347	14131
30779332	Negative_Correlation	MESH:C049347	16171
30779332	Positive_Correlation	MESH:C049347	16153
30779332	Association	MESH:C049347	12775
30779332	Negative_Correlation	MESH:C049347	16193
30779332	Positive_Correlation	MESH:C049347	17470
30779332	Negative_Correlation	MESH:C049347	15978
30779332	Association	MESH:C049347	17533
30779332	Negative_Correlation	MESH:C049347	19878
30779332	Association	MESH:C049347	12525
30779332	Positive_Correlation	MESH:C049347	12064
30779332	Association	MESH:C049347	14130
30779332	Negative_Correlation	MESH:C049347	MESH:D009103
30779332	Negative_Correlation	MESH:C049347	MESH:D007249
30779332	Negative_Correlation	MESH:C049347	12504
30779332	Negative_Correlation	MESH:C049347	17709
30779332	Negative_Correlation	MESH:C049347	21926

